Top Page
Centrica
(LSE:CNA)
Centrica (CNA) vs. S&P 500 (SPY)
Centrica Business Overview & Revenue Model
Centrica Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 20.48B | 26.46B | 23.74B | 14.74B | 12.25B | 12.99B | Gross Profit |
| 9.24B | -1.70B | 9.75B | 1.41B | 3.52B | 4.64B | EBIT |
| 4.68B | 6.51B | 8.31B | 244.00M | 1.87B | 2.58B | EBITDA |
| 4.13B | 7.08B | 410.00M | 721.00M | 488.00M | 193.00M | Net Income Common Stockholders |
| 1.10B | 3.93B | -782.00M | 586.00M | 41.00M | -964.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 6.85B | 6.85B | 4.84B | 5.06B | 1.82B | 1.47B | Total Assets |
| 21.37B | 21.37B | 29.04B | 27.09B | 17.12B | 18.15B | Total Debt |
| 4.05B | 4.10B | 3.96B | 4.58B | 5.29B | 5.26B | Net Debt |
| -2.39B | -2.34B | -880.00M | -485.00M | 3.47B | 3.92B | Total Liabilities |
| 17.13B | 17.13B | 27.76B | 24.34B | 15.74B | 16.36B | Stockholders Equity |
| 3.88B | 3.88B | 1.02B | 2.37B | 957.00M | 1.21B |
| Cash Flow | Free Cash Flow | ||||
| 893.00M | 2.42B | 943.00M | 1.19B | 778.00M | 493.00M | Operating Cash Flow |
| 1.21B | 2.75B | 1.31B | 1.61B | 1.27B | 1.25B | Investing Cash Flow |
| -444.00M | 115.00M | -566.00M | 2.26B | -354.00M | -503.00M | Financing Cash Flow |
| -1.70B | -1.41B | -917.00M | -938.00M | -280.00M | -1.08B |
Centrica Technical Analysis
Centrica Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £7.43B | 5.85 | 32.10% | 2.77% | -24.74% | -63.34% | |
71 Outperform | £8.22B | 35.23 | 17.17% | 4.34% | 5.38% | 86.34% | |
71 Outperform | £18.03B | 9.28 | 21.94% | 3.73% | -13.09% | 231.40% | |
67 Neutral | £52.84B | 25.01 | 5.28% | 5.09% | -6.68% | -77.57% | |
64 Neutral | £7.58B | 66.99 | 5.50% | 4.54% | 8.61% | ― | |
62 Neutral | $8.60B | 12.04 | 6.29% | 4.50% | 3.04% | -9.39% |
Centrica Corporate Events
Centrica plc announced the purchase of 3,914,749 of its own ordinary shares at a price of 151.79 pence per share, as part of its extended 2024-25 buyback program. This transaction, executed through Merrill Lynch International, reflects Centrica’s ongoing strategy to manage its capital structure and enhance shareholder value, with a total of 48,166,613 shares purchased since March 2025.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s stock score benefits from strong technical indicators and attractive valuation metrics. The company’s enhanced financial health in 2024 and strategic share buybacks further bolster its outlook. However, historical financial volatility and debt reliance necessitate cautious optimism.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 100,000 of its own ordinary shares at a price of 149.51 pence per share, as part of its ongoing 2024-25 buyback programme. This transaction is part of a broader strategy to manage its capital structure and potentially enhance shareholder value, reflecting Centrica’s commitment to returning capital to shareholders.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica presents a promising investment opportunity with strong technical indicators and attractive valuation metrics. The company’s financial performance has improved, though historical volatility and debt reliance continue to pose risks. The robust share buyback program and director share acquisitions signal confidence and are significant positives. Overall, the stock merits a favorable outlook, balanced by cautious optimism regarding financial volatility.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc announced that Sue Whalley, a Non-Executive Director, has purchased 10,000 ordinary shares of the company at a price of £1.492892 per share, totaling £14,928.92. This transaction, conducted on the London Stock Exchange, signifies a vote of confidence in the company’s prospects and may influence stakeholder perceptions positively.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s robust share buyback program and attractive valuation metrics are significant strengths. Despite improved financial performance in 2024, historical volatility and reliance on debt remain concerns. However, technical stability and a strong buyback strategy support a favorable outlook.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 100,084 ordinary shares at a price of 149.54 pence each, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a larger strategy that has seen the company acquire over 44 million shares since March 2025, reflecting Centrica’s commitment to returning value to its shareholders and optimizing its capital structure.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s robust share buyback program and attractive valuation metrics are significant strengths. Despite improved financial performance in 2024, historical volatility and reliance on debt remain concerns. However, technical stability and a strong buyback strategy support a favorable outlook.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 1,896,123 of its own ordinary shares at a price of 147.02 pence per share, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, increases the company’s treasury shares to 466,843,670, indicating a strategic move to manage its share capital and potentially enhance shareholder value.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s robust share buyback program and attractive valuation metrics are significant strengths. Despite improved financial performance in 2024, historical volatility and reliance on debt remain concerns. However, technical stability and a strong buyback strategy support a favorable outlook.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 4,429,875 of its own ordinary shares at a price of 145.10 pence each, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, increases the company’s treasury shares to 464,947,547, potentially impacting its market positioning by reducing the number of shares in circulation and possibly enhancing shareholder value.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica presents a strong investment case with solid technical indicators and attractive valuation metrics. The ongoing share buyback program further enhances shareholder value. While financial metrics have improved, past volatility necessitates cautious optimism.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 69,960 of its own ordinary shares at a price of 143.12 pence per share, as part of its ongoing 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a broader strategy to manage the company’s capital structure and enhance shareholder value. Following this purchase, Centrica holds a significant number of shares in treasury, indicating a strong position in managing its equity and signaling confidence in its financial health.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica boasts a strong valuation and solid technical indicators, bolstered by an active share buyback program that supports shareholder value. Despite improved financial metrics in 2024, historical volatility and debt reliance pose risks. The lack of recent earnings call data prevents a complete assessment, but the robustness in valuation and technical aspects suggests a favorable outlook.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the acquisition of ordinary shares under its Share Incentive Plan by two of its executive directors, Christopher O’Shea and Russell O’Brien. This transaction, conducted on April 10, 2025, involves the purchase of both Partnership Shares and Matching Shares, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica boasts a strong valuation and solid technical indicators, bolstered by an active share buyback program that supports shareholder value. Despite improved financial metrics in 2024, historical volatility and debt reliance pose risks. The lack of recent earnings call data prevents a complete assessment, but the robustness in valuation and technical aspects suggests a favorable outlook.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has executed a share buyback transaction, purchasing 53,009 ordinary shares at an average price of 142.88 pence per share through Merrill Lynch International. This move is part of the company’s ongoing 2024-25 buyback program, which aims to enhance shareholder value by reducing the number of shares in circulation. As of this purchase, Centrica holds 460,447,712 shares in treasury, reflecting its strategic focus on capital management and shareholder returns.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s stock score reflects a balanced outlook, with a strong valuation and technical performance. The company’s financial health has improved, though historical volatility in financial metrics remains a concern. The share buyback program further supports shareholder value, indicating a strategic focus on optimizing capital structure. While the company shows promise, its historical financial volatility warrants cautious optimism.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc announced the purchase of 91,844 of its own ordinary shares at a price of 139.85 pence per share, as part of its ongoing 2024-25 buyback programme. This move, executed through Merrill Lynch International, reflects Centrica’s strategy to manage its share capital effectively, potentially impacting shareholder value and market perception positively.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s overall stock score reflects strong technical performance and attractive valuation metrics, supported by a robust share buyback program. While financial improvements are evident, historical volatility in financial performance warrants cautious optimism. Continued focus on managing leverage and stabilizing revenue streams will be key for sustained success.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 2,003,057 of its own ordinary shares at a price of 141.21 pence per share, as part of an extension to its 2024-25 buyback program. This transaction, executed through Merrill Lynch International, reflects Centrica’s ongoing efforts to manage its capital structure and return value to shareholders. The company now holds 460,302,859 shares in treasury, with a total of 5,032,804,355 shares in issue. This move is likely to impact Centrica’s financial positioning by consolidating its share capital and potentially enhancing shareholder value.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica demonstrates strong technical performance and attractive valuation metrics, supported by a robust share buyback program. While financial improvements are evident, historical volatility in financial performance warrants cautious optimism.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc has announced the purchase of 4,271,718 of its own ordinary shares at a price of 140.05 pence per share, as part of its extended 2024-25 buyback program. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with the purchased shares being held as treasury shares. Since March 2025, Centrica has acquired a total of 35,507,912 shares, reflecting a significant investment in its own stock, which may impact its market positioning and shareholder value.
Spark’s Take on GB:CNA Stock
According to Spark, TipRanks’ AI Analyst, GB:CNA is a Outperform.
Centrica’s robust technical indicators and strong valuation metrics are the main strengths, bolstered by a significant share buyback program. However, historical financial volatility and reliance on debt remain concerns.
To see Spark’s full report on GB:CNA stock, click here.
Centrica plc announced the purchase of 270,778 of its own ordinary shares at a price of 149.51 pence per share, as part of its ongoing 2024-25 buyback program. This transaction, conducted through Merrill Lynch International, reflects Centrica’s strategic efforts to manage its share capital and potentially enhance shareholder value.
Centrica plc has announced the purchase of 65,796 of its own ordinary shares at a price of 152.16 pence per share, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a broader strategy to manage the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation.
Centrica plc has announced the purchase of 65,811 ordinary shares at a price of 150.64 pence per share as part of its extended 2024-25 buyback programme. This acquisition, executed through Merrill Lynch International, reflects Centrica’s ongoing efforts to manage its share capital, enhancing shareholder value and potentially impacting its market positioning by holding a substantial number of treasury shares.
Centrica plc has announced the purchase of 1,771,721 ordinary shares at a price of 151.80 pence per share as part of its extended 2024-25 buyback programme. The shares will be held as treasury shares, and this move is part of a broader strategy to manage the company’s capital structure and enhance shareholder value.
Centrica plc announced that as of March 31, 2025, its issued capital comprised over 5.4 billion ordinary shares, with a significant portion held in treasury, leaving over 5 billion shares with voting rights. This information is crucial for shareholders and others with notification obligations to determine their interest in the company under regulatory rules.
Centrica plc has announced the purchase of 3,855,826 of its own ordinary shares at a price of 149.04 pence per share, as part of its extended 2024-25 buyback programme. This move, executed through Merrill Lynch International, is part of Centrica’s strategy to manage its capital structure and enhance shareholder value, reflecting its ongoing commitment to returning capital to shareholders.
Centrica plc has announced the purchase of 66,631 of its own ordinary shares at a price of 149.90 pence each, as part of its ongoing 2024-25 share buyback program. This transaction, executed through Merrill Lynch International, is part of a broader strategy to manage the company’s capital structure and enhance shareholder value, with a total of over 25 million shares purchased since early March 2025.
Centrica plc announced the grant of Restricted Share Plan (RSP) awards to two of its Executive Directors, Chris O’Shea and Russell O’Brien, under the Centrica Long Term Incentive Plan. These awards, which are contingent on continued employment and performance criteria over a three-year period, reflect the company’s commitment to aligning executive incentives with long-term company performance. Additionally, shares were acquired by the Executive Directors as part of the Annual Incentive Plan for the 2024 financial year, demonstrating Centrica’s strategy to retain key personnel and enhance shareholder value through equity-based compensation.
Centrica plc announced that its Executive Directors, Chris O’Shea and Russell O’Brien, acquired shares as part of a Free Share Award under the company’s Share Incentive Plan. This acquisition, which took place on March 27, 2025, involves a three-year holding period and reflects the company’s ongoing efforts to align executive interests with shareholder value. The transaction was conducted outside a trading venue, with each director acquiring 948 shares at a price of £1.4763333 per share, totaling £1,399.56.
Centrica plc announced the purchase of 66,910 ordinary shares at 148.73 pence each as part of its extended 2024-25 buyback program. This move, executed through Merrill Lynch International, is part of a broader strategy to manage its share capital, with the company having acquired over 25 million shares since March 2025, reflecting a significant investment in its own equity.
Centrica plc has announced the availability of its Notice of Annual General Meeting (AGM) for shareholders, following the digital release of its 2024 Annual Report and Accounts. The AGM is scheduled for 8 May 2025, with options for shareholders to attend in person or remotely, emphasizing the company’s commitment to accessibility and transparency in its shareholder communications.
Centrica plc has announced the purchase of 67,297 of its own ordinary shares at a price of 147.89 pence each, as part of its ongoing 2024-25 buyback program. This transaction, executed through Merrill Lynch International, reflects Centrica’s strategy to manage its capital structure and enhance shareholder value. The company now holds 475,136,248 shares in treasury, with a total of 5,017,970,966 shares in issue. This move is part of a broader effort to stabilize its market position and provide returns to stakeholders.
Centrica plc announced that its directors, Amber Rudd and Philippe Boisseau, have acquired ordinary shares in the company as part of their Share Purchase Agreements. These transactions, conducted on the London Stock Exchange, reflect the directors’ investment in the company’s future, potentially signaling confidence in Centrica’s market positioning and operational strategies.
Centrica plc has announced the purchase of 1,991,396 of its own ordinary shares at a price of 147.68 pence each, as part of its ongoing share buyback program. This transaction, conducted through Merrill Lynch International, is part of an extended buyback initiative aimed at optimizing the company’s capital structure, with Centrica now holding 475,068,951 shares in treasury. This move is expected to enhance shareholder value and reflects Centrica’s commitment to returning capital to its investors.
Centrica plc announced the purchase of 4,230,447 of its own ordinary shares at an average price of 146.69 pence per share, as part of its ongoing 2024-25 buyback programme. This move, executed through Merrill Lynch International, is part of a strategic effort to manage the company’s capital structure and enhance shareholder value, with a total of 23,014,028 shares purchased since March 2025. The company now holds 473,077,555 shares in treasury, reflecting its commitment to optimizing its financial operations and market positioning.
Centrica plc announced the purchase of 68,990 of its own ordinary shares at a price of 145.02 pence per share as part of its ongoing 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a broader strategy to manage the company’s capital structure and enhance shareholder value by holding these shares in treasury. Since the beginning of March 2025, Centrica has acquired a total of 18,783,581 shares, reflecting its commitment to the buyback initiative.
Centrica plc has announced the purchase of 66,381 of its own ordinary shares at a price of 144.80 pence per share on March 20, 2025, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, reflects Centrica’s ongoing efforts to manage its capital structure and potentially enhance shareholder value, with the company now holding a total of 468,778,118 shares in treasury.
Centrica plc announced a change in the voting rights held by JPMorgan Chase & Co., which now holds 5.297522% of the voting rights in the company. This adjustment in holdings may influence Centrica’s shareholder dynamics and could have implications for its corporate governance and strategic decisions.
Centrica plc has announced a change in its major holdings due to an acquisition or disposal of voting rights by JPMorgan Chase & Co. This transaction resulted in JPMorgan holding a total of 5.549871% of voting rights in Centrica, an increase from the previous 5.257960%. This adjustment in holdings could influence Centrica’s governance and strategic decisions, potentially impacting stakeholders and market perceptions.
Centrica plc has announced the purchase of 1,306,478 of its own ordinary shares at a price of 144.22 pence per share, as part of its ongoing 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a broader strategy to manage the company’s capital structure and return value to shareholders, with a total of 18,648,210 shares purchased since March 2025 at a cost of over £27 million.
Centrica plc has announced the purchase of 1,553,691 of its own ordinary shares at a price of 144.31 pence per share, as part of its extended 2024-25 buyback programme. This transaction, conducted through Merrill Lynch International, reflects Centrica’s ongoing strategy to manage its capital structure and enhance shareholder value, holding a total of 467,405,259 shares in treasury following this purchase.
Centrica plc has published its 2024 Annual Report and Accounts, following the preliminary results announcement made in February 2025. The report is available on the company’s website and will be submitted to the National Storage Mechanism for public inspection. This release provides stakeholders with comprehensive insights into the company’s financial performance and significant events from the 2024 financial year.
Centrica plc has announced the purchase of 3,505,971 of its own ordinary shares at an average price of 144.27 pence per share, as part of its extended 2024-25 buyback program. This move, facilitated through Merrill Lynch International, is part of the company’s strategic efforts to manage its capital structure and enhance shareholder value, with a total of 15,788,041 shares purchased since March 3, 2025, amounting to over £23 million.
Centrica plc announced the purchase of 200,000 of its own ordinary shares at a price of 143.98 pence per share, as part of its extended 2024-25 buyback program. This transaction, facilitated through Merrill Lynch International, reflects the company’s ongoing efforts to manage its capital structure and enhance shareholder value. Following this purchase, Centrica holds a substantial number of shares in treasury, indicating a strategic move to bolster its market position and potentially increase earnings per share.
Centrica plc announced the purchase of 69,557 ordinary shares at a price of 143.98 pence each, as part of its ongoing share buyback program. This transaction, conducted through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. Following this purchase, Centrica holds a substantial number of shares in treasury, indicating a continued commitment to its buyback initiative, which could positively impact its market positioning and shareholder returns.
Centrica plc has announced the purchase of 69,687 of its own ordinary shares at a price of 143.86 pence per share, as part of its extended 2024-25 buyback program. This move is part of a non-discretionary share repurchase agreement with Merrill Lynch International, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value. Following this transaction, Centrica holds 462,076,040 shares in treasury, with a total of 5,031,031,174 shares in issue.
Centrica plc announced that its executive directors, Christopher O’Shea and Russell O’Brien, have acquired shares under the company’s Share Incentive Plan. The transactions involved the acquisition of Partnership and Matching Shares, with a total of 125 shares acquired at an average price of £1.464 per share. This move is part of Centrica’s ongoing efforts to align management interests with shareholder value, potentially impacting the company’s market perception and investor confidence.
Centrica plc has announced the purchase of 1,862,301 of its own ordinary shares at a price of 144.34 pence per share, as part of its extended 2024-25 buyback programme. This transaction, executed through Merrill Lynch International, is part of a larger effort since March 3, 2025, where the company has acquired nearly 12 million shares, indicating a strategic move to manage its capital structure and potentially enhance shareholder value.
Centrica plc has announced the purchase of 4,014,334 of its own ordinary shares at a price of 146.36 pence each, as part of its extended 2024-25 buyback programme. This transaction, facilitated by Merrill Lynch International, is part of a larger strategy to manage the company’s capital structure and enhance shareholder value, with a total of 10,080,525 shares purchased since March 3, 2025, at a cost of £14,875,701.01. The impact of this buyback is expected to strengthen Centrica’s market position and potentially improve its stock performance, benefiting stakeholders.
Centrica plc announced the purchase of 100 ordinary shares at a price of 146.77 pence per share, as part of its ongoing share buyback program. This transaction, executed through Merrill Lynch International, is part of the company’s strategy to manage its capital structure and return value to shareholders. Since March 3, 2025, Centrica has acquired over 6 million shares, reflecting a significant investment in its own stock, which may impact its market positioning and shareholder value.
Centrica plc announced the purchase of 4,400 of its own ordinary shares at a price of 147.52 pence per share, as part of its ongoing 2024-25 share buyback program. This transaction, conducted through Merrill Lynch International, is part of a larger effort that has seen the company acquire over 6 million shares since March 3, 2025, at a total cost of over £9 million. The repurchase of shares is intended to be held as treasury shares, potentially impacting the company’s share value and market perception positively.
Centrica plc has announced the purchase of 1,865,096 of its own ordinary shares at an average price of 146.86 pence per share, as part of its extended 2024-25 buyback program. This transaction, executed through Merrill Lynch International, reflects Centrica’s ongoing efforts to manage its capital structure and potentially enhance shareholder value, with a total of 6,061,591 shares purchased since March 3, 2025, costing approximately £8.99 million.
Centrica plc has announced the purchase of 4,196,495 of its own ordinary shares at a price of 149.04 pence per share, as part of its ongoing 2024-25 buyback program. This transaction, executed through Merrill Lynch International, reflects Centrica’s strategic efforts to manage its share capital and potentially enhance shareholder value. Following this purchase, Centrica holds 454,305,345 shares in treasury, with 5,038,801,869 ordinary shares remaining in issue. The buyback is expected to impact the company’s financial structure and market perception positively.
Centrica plc has announced the purchase of 4,196,495 of its own ordinary shares at a price of 149.04 pence per share, as part of its extended 2024-25 buyback programme. This move, executed through Merrill Lynch International, aims to consolidate its share capital and potentially enhance shareholder value by holding these shares in treasury, reflecting Centrica’s strategic financial management and commitment to optimizing its capital structure.
Centrica plc announced the total voting rights as of February 28, 2025, with an issued capital comprising over 5.4 billion ordinary shares, of which approximately 5 billion shares have voting rights. This information is crucial for shareholders and others with notification obligations to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
Centrica plc has announced an extension of its share buyback program by £500 million, bringing the total to £2.0 billion, to be completed by the end of 2025. The company has amended its agreement with Merrill Lynch to facilitate this extension, with the repurchase period now ending on 13 June 2025. Additionally, Centrica has completed a significant share repurchase through Goldman Sachs, buying 181,529,791 ordinary shares at an average price of 126.70 pence per share, totaling approximately £230 million. This move is likely to impact the company’s financial structure and shareholder value positively.
Centrica plc has announced the purchase of 881,210 of its own ordinary shares at a price of 148.6977 pence per share, as part of its ongoing share buyback programme. This move, facilitated through Goldman Sachs International, is part of a broader strategy to manage the company’s capital structure and return value to shareholders. Since August 2024, Centrica has repurchased over 181 million shares, reflecting a significant investment in its own equity, which may enhance shareholder value and improve earnings per share. The company now holds over 450 million shares in treasury, indicating a robust approach to capital management.
Centrica plc has announced the purchase of 1,254,657 of its own ordinary shares at a price of 147.0300 pence per share, as part of its ongoing buyback programme. This transaction, executed through Goldman Sachs International, is part of a broader strategy initiated in August 2024, aimed at consolidating its share capital and potentially enhancing shareholder value.
Centrica plc has announced the purchase of 1,200,000 of its own ordinary shares at a price of 149.3300 pence per share, as part of its ongoing share buyback program initiated in August 2024. This transaction, executed through Goldman Sachs International, reflects Centrica’s strategic financial management and aims to enhance shareholder value by holding the purchased shares as treasury shares. Following this purchase, Centrica holds 447,972,983 shares in treasury, with 5,045,134,231 shares remaining in issue.
Centrica plc announced that Amber Rudd, a Non-Executive Director, has acquired ordinary shares in the company. This transaction, conducted on the London Stock Exchange, reflects the director’s engagement with the company’s share purchase agreement, potentially indicating confidence in Centrica’s market position and future prospects.
Centrica plc has announced the purchase of 1,370,591 of its own ordinary shares at a price of 151.0900 pence per share, as part of its ongoing share buyback program. This program, which began on 8 August 2024, has seen the company acquire a total of 178,193,924 shares, costing over £225 million. The recent transaction increases Centrica’s treasury shares to 446,772,983, with the company having 5,046,334,231 shares in issue. This buyback initiative is part of Centrica’s strategy to manage its capital structure and return value to shareholders, potentially impacting its market positioning and investor relations.
Centrica plc has announced the purchase of 1,853,435 of its own ordinary shares at a price of 150.7100 pence per share, as part of its ongoing share buyback program. This transaction, executed through Goldman Sachs International, is part of a larger initiative that began in August 2024, with the company having acquired a total of 176,823,333 shares since then. The buyback is intended to optimize the company’s capital structure and potentially enhance shareholder value, reflecting Centrica’s strategic financial management and commitment to returning value to its investors.
Centrica plc announced the cancellation of 75 million ordinary shares held in treasury, aligning with its policy to keep treasury shares below 10% of total issued share capital. This move reduces the total number of treasury shares to 443,548,957, representing 8.07% of the company’s total issued share capital, potentially enhancing shareholder value and optimizing the company’s capital structure.
Centrica plc recently executed a share buyback, purchasing 750,000 of its ordinary shares at a price of 146.8100 pence each, which will be held as treasury shares. This transaction is part of an ongoing buyback program established in August 2024, aiming to manage capital efficiency and shareholder value, with Centrica having bought back nearly 175 million shares to date.
Centrica plc has executed a purchase of 1,000,000 ordinary shares at an average price of 145.4100 pence per share, as part of its ongoing share buyback program initiated in August 2024. This move is aligned with the company’s strategy to manage its capital structure efficiently, potentially enhancing shareholder value and reinforcing its market position.
Centrica is expanding its investment in Ireland’s energy market by increasing its electricity generation capacity by 50% to 1GW, which will support energy supply security and decarbonization efforts. This expansion includes a new 334MW power station in Galway capable of using biomethane or hydrogen blend fuel, and a 5-year contract for the existing Whitegate power station in Cork, both of which will be critical for Ireland’s strategic energy infrastructure. These investments align with Centrica’s strategy to enhance energy transition and provide attractive returns for shareholders while supporting reliable energy supply.
Centrica has signed a significant Sale and Purchase Agreement with Petrobras for 0.8 million tons of LNG annually over 15 years, starting in 2027. This agreement highlights Centrica’s strategic move to expand its LNG portfolio globally, enhance its market presence in Brazil, and strengthen energy security with a long-term partner. It reflects Centrica’s commitment to the energy transition and portfolio risk management, while Petrobras benefits from reduced market volatility and increased competitiveness.
Centrica has completed its triennial review of its UK defined benefit pension schemes, reporting a revised technical provisions deficit of £504 million as of March 2024, down from £944 million in 2021. The company will make annual deficit payments of approximately £140 million until 2027, highlighting the collaborative relationship with pension scheme trustees and improving financial clarity.
Centrica plc announced its preliminary financial results for the year ending December 31, 2024, revealing a proposed final dividend of 3.0p per share, bringing the total dividend for the year to 4.5p per share, up from 4.0p in 2023. This decision reflects the company’s strategy to return profits to shareholders while retaining sufficient reserves for future investments, thereby strengthening its financial stability and commitment to long-term growth. The final dividend is subject to approval at the Annual General Meeting scheduled for May 8, 2025, with payment to be made on June 5, 2025, to shareholders registered by May 2, 2025.
Centrica plc has executed a share buyback transaction, purchasing 988,358 ordinary shares through Goldman Sachs International to hold as treasury shares. This transaction is part of an ongoing buyback program initiated in August 2024, through which Centrica has acquired over 173 million shares at a cost exceeding £217 million. The purchase aims to optimize the company’s capital structure, potentially enhancing shareholder value and market confidence.
Centrica plc has announced the purchase of 1,100,000 of its own ordinary shares at an average price of 134.4300 pence per share, as part of its ongoing share buyback programme. Since August 2024, Centrica has repurchased over 172 million shares, aiming to enhance shareholder value and optimize its capital structure, reflecting positively on its market position and corporate strategy.
Centrica plc has announced the purchase of 1,111,681 of its own ordinary shares, executed through Goldman Sachs International, at an average price of 136.9900 pence per share. This transaction is part of Centrica’s ongoing share buyback program initiated in August 2024, which has led to the repurchase of over 171 million shares at a cost exceeding £214 million. This buyback strategy indicates Centrica’s efforts to consolidate its market position and potentially enhance shareholder value by reducing the number of shares in circulation, thereby boosting earnings per share.
Centrica plc announced the purchase of 600,000 ordinary shares at a price of 135.9100 pence each, part of its ongoing share buyback programme initiated in August 2024. This move is part of Centrica’s strategy to manage its capital more effectively, potentially increasing shareholder value by reducing the number of shares outstanding.
Centrica plc has executed a purchase of 700,000 of its own ordinary shares at an average price of 134.9200 pence per share, as part of its ongoing share buyback program. This move, in collaboration with Goldman Sachs International, aims to enhance shareholder value, holding the purchased shares in treasury while maintaining substantial shares in issue. Such buybacks are often seen as a strategy to consolidate company ownership and positively impact stock prices, potentially benefiting existing shareholders.
Centrica plc announced the acquisition of ordinary shares under its Share Incentive Plan by two of its executive directors, Christopher O’Shea and Russell O’Brien. The transactions, notified under the Market Abuse Regulation, involve the purchase of Partnership and Matching Shares, highlighting the company’s commitment to aligning the interests of its leadership with shareholders.
Centrica plc announced the repurchase of 1,294,838 ordinary shares as part of its ongoing share buyback program, executed through Goldman Sachs International. This transaction is part of a larger buyback initiative that has seen Centrica repurchase a significant number of shares since August 2024, reflecting the company’s strategic efforts to manage its capital structure and return value to shareholders.
Centrica plc recently executed a buyback of 1,376,769 ordinary shares at a price of 140.5300 pence per share as part of its ongoing share buyback program. This move is a continuation of its strategy announced in August 2024, aimed at optimizing its capital structure. The shares will be held as treasury shares, contributing to a total of 511,025,971 shares held in treasury. This activity underscores Centrica’s commitment to enhancing shareholder value and reflects its strong financial position.
Centrica plc has recently enhanced its share buyback program by purchasing 1.4 million of its own shares at an average price of 139.52 pence per share, executed through Goldman Sachs International. This transaction, part of the company’s ongoing buyback strategy initiated in August 2024, reinforces Centrica’s commitment to returning value to its shareholders by holding a total of over 509 million shares in treasury, impacting its overall stock market position.
Centrica plc has announced the purchase of 600,000 of its own ordinary shares at a price of 136.5 pence per share, as part of its ongoing share buyback program initiated in August 2024. This initiative is executed through Goldman Sachs International and aims to consolidate the company’s equity by holding these shares in treasury, thereby potentially enhancing shareholder value.
Centrica plc announced the purchase of 598,668 of its own ordinary shares at a price of 141.4800 pence per share, as part of its ongoing buyback program. This initiative, conducted through Goldman Sachs International, is part of a larger effort to repurchase shares, having acquired over 164 million shares since August 2024, demonstrating a strategic move to manage its capital structure and potentially increase shareholder value.
Centrica plc announced the purchase of 685,938 of its ordinary shares on 5 February 2025, as part of an ongoing buyback programme. This strategic move, executed through Goldman Sachs International, reflects the company’s efforts to enhance shareholder value and manage its capital structure effectively.
Centrica plc has executed a share buyback program, purchasing 1,432,458 ordinary shares on February 4, 2025, at an average price of 141.5100 pence per share. This transaction is part of a larger buyback initiative that started in August 2024, through which the company has acquired over 162 million shares, indicating a strategic move to optimize its capital structure and potentially enhance shareholder value.
Centrica plc announced the purchase of 1,345,443 ordinary shares at a price of 142.8600 pence per share as part of its ongoing buyback programme. This effort, managed through Goldman Sachs International, reflects Centrica’s commitment to enhancing shareholder value by holding these shares as treasury shares, thus reducing the number of shares in circulation and potentially increasing earnings per share.
Centrica plc has announced a total of 5,568,107,214 issued ordinary shares as of January 31, 2025, with 503,586,695 shares held in treasury. The remaining 5,064,520,519 shares carry voting rights, which stakeholders can use to determine the necessity of notifying any changes in their shares under the Disclosure Guidance and Transparency Rules.
Centrica plc announced the purchase of 1,000,000 of its ordinary shares on January 31, 2025, at a price of 141.5900 pence per share. These shares will be retained as treasury shares, in line with the company’s ongoing buyback program initiated in August 2024. Since the commencement of the buyback program, Centrica has acquired nearly 160 million shares at a cost of over £199 million. The purchase strengthens Centrica’s financial position by increasing its treasury share holdings to over 503 million shares, potentially impacting share value and investor confidence.
Centrica plc announced the purchase of 1,000,000 of its own ordinary shares at an average price of 138.8600 pence per share as part of its buyback program. This purchase is part of an ongoing effort that began on 8 August 2024, through which the company has repurchased 158,985,745 shares, reflecting its strategy to return value to shareholders and optimize its capital structure. The buyback is conducted through a non-discretionary agreement with Goldman Sachs International, and following this transaction, Centrica holds 502,588,518 shares in treasury, impacting its share capital and potentially influencing investor relations.
Centrica plc has executed a share buyback transaction, purchasing 1,000,000 ordinary shares at a price of 137.9300 pence per share, which will be held as treasury shares. This buyback is part of a previously announced program and highlights the company’s strategy to manage its capital and enhance shareholder value, indicating a strong financial position.
Centrica plc announced the purchase of 1,440,017 ordinary shares through Goldman Sachs International as part of its ongoing share buyback programme. Since the initiation of the programme in August 2024, the company has repurchased over 156 million shares, enhancing its treasury holdings and potentially impacting its market value and shareholder returns.
Centrica plc has announced the purchase of 1,545,564 of its own shares, executed through Goldman Sachs International, at a price of 133.5300 pence per share. This transaction is part of the company’s ongoing buyback programme which began in August 2024, aimed at consolidating its market position by holding shares in treasury, with significant implications for shareholder value and market perception.
Centrica plc announced that Amber Rudd, a Non-Executive Director, has acquired ordinary shares of the company as part of a Share Purchase Agreement. The transaction, worth £2,249.17, was conducted on the London Stock Exchange, reflecting ongoing engagement and investment by the company’s leadership in its operations.
Centrica plc recently executed a share buyback, purchasing 1,065,000 ordinary shares at an average price of 135.2100 pence per share through Goldman Sachs International. This transaction is part of an ongoing buyback program, which has seen Centrica repurchase over 154 million shares since August 2024, reflecting its commitment to enhancing shareholder value.
Centrica plc announced the purchase of 1,063,234 of its own ordinary shares at a price of 137.0600 pence per share, as part of its ongoing buyback programme. This initiative, in collaboration with Goldman Sachs International, demonstrates Centrica’s strategic focus on consolidating its market position and potentially enhancing shareholder value through the reduction of outstanding shares.
Centrica plc has recently repurchased 1,497,436 ordinary shares at an average price of 137.0400 pence per share as part of its ongoing share buyback program. This initiative, conducted through Goldman Sachs International, is part of a larger strategy initiated in August 2024, which has seen the company acquire over 151 million shares, potentially enhancing shareholder value and optimizing capital structure.